Karla Kurrelmeyer, MD, FACC, FASE

Karla Kurrelmeyer, MD, FACC, FASE

Houston Methodist

Associate Professor of Clinical Cardiology, Academic Institute Assistant Clinical Member, Research Institute Houston Methodist Weill Cornell Medical College

Expertise: Heart FailureInflammationDiastolic Heart FailureCytokinesAortic RegurgitationAnticoagulation for Atrial Fibrillation

Dr. Kurrelmeyer began her research activities while still a cardiology fellow at the Baylor College of Medicine where she won the Best Basic Research Award in 1998. That same year, she was also the recipient of the American Heart Association Melvin L. Marcus Young Investigator Award in Cardiovascular Science. Dr. Kurrelmeyer stayed at Baylor after completing her fellowship and was appointed as an Assistant Professor of Medicine there in 2000. She joined the Physician´s Organization at Methodist in 2005 and received her faculty appointment at the Weill Medical School the following year.

Dr. Kurrelmeyer´s research centers on the role of inflammatory cytokines on disease progression in heart failure. She also conducts investigations into new treatments for diastolic heart failure and aortic regurgitation.

No Research/Citations

No Pitches / Articles Found

“Heart disease, not breast cancer, is the number one killer of women in the United States,”

- Houston Methodist Hospital hosts seminar on women and heart disease

"Women with anxiety should be treated seriously because frequently they have ischemia . . . and doctors need to do more diagnostic testing to make sure symptoms are due to anxiety instead of obstructive coronary artery disease,"

- Anxiety in Women May Mask Heart Disease Symptoms Researchers Say

"Because atrial fibrillation increases a woman's risk of complications, it also slightly increases her risk for death, depending on how bad her stroke, heart failure, or heart attack is."

- Atrial Fibrillation: What Women Need to Know

Available for logged-in users onlyLogin HereorRegister
close
0.18139